Vault-13

GENENTA SCIENCE S P A GNTA

SPONSORED ADS · ADR · CUSIP 36870W100

4 institutional holders +0 vs Q1 2022
3,7093.7k shares reported held*
$27.0kreported value*
1 new 1 added 1 reduced 1 sold out net sold ≈ $345.1k (-43.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $7.28.

Trends to Q2 2022

Institutional holders

Managers reporting a position, each quarter

024Q4 21: 3Q1 22: 4Q2 22: 44Q4 21Q1 22Q2 22
Numbers
QuarterHolders
Q4 20213
Q1 20224
Q2 20224

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
202Q1 22: 1 bought or addedQ1 22: 1 cut or sold outQ1 22Q2 22: 2 bought or addedQ2 22: 2 cut or sold outQ2 22
Numbers
QuarterBought or addedCut or sold out
Q1 202211
Q2 202222

Biggest buyers

UBS Group AG Added +865+865
MORGAN STANLEY New +500+500

Biggest sellers

ALGEBRIS (UK) LTD Sold out -45,000-45.0k
BANK OF AMERICA CORP /DE/ Reduced -30-30

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Nuzzo Marco 13D · may seek influence -11.5 pts · filed 2026-10-02
Stated purposeItem 4 is hereby amended and supplemented by adding the following thereto: On June 12, 2026, the Court of Milan granted interim relief suspending the effectiveness of the resolution adopted at the Issuer's extraordinary shareholders' meeting on October 29, 2025 concerning the amendment to the Issuer's corporate purpose. On July 9, 2026, a panel of the Court of Milan revoked that interim relief following a challenge filed by the Issuer. The proceedings on the merits remain pending. Between August 7, 2026 and August 19, 2026, Fin Posillipo S.p.A. ("Posillipo") acquired 110,000 ADSs in open-market transactions at a price of $1.30 per ADS. Posillipo made these purchases for its own account. The purchases were not planned, directed, or coordinated by, and were not made pursuant to any agreeme… Full filing
11.5% -11.5 pts 5.5m 2026-10-02
Pierluigi Paracchi 13G · exempt (held before listing) -2.8 pts · filed 2026-01-27 9.8% -2.8 pts 2.3m 2026-01-27

Holders, Q2 2022

#ManagerLocationShares Value% of their portfolioChangeShares change
1 UBS Group AG 0.00% of their portfolio ZURICH, V8 2,8282.8k $20.0k $20.0k 0.00% Added +865 +865
2 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 500500 $4.0k $4.0k 0.00% New
3 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 381381 $3.0k $3.0k 0.00% Reduced -30 -30
4 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged